Question 1

Does Walleye Capital own ABCL stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Walleye Capital holds 139,672 shares of ABCL (AbCellera Biologics), worth $2M.

Question 2

How many shares of ABCL does Walleye Capital own?

Accepted Answer

As of its Q3 2026 13F, Walleye Capital holds 139,672 shares of ABCL (AbCellera Biologics).

Question 3

What is Walleye Capital's ABCL position worth?

Accepted Answer

As of its Q3 2026 13F, Walleye Capital's ABCL position is worth $2M.

Question 4

Is Walleye Capital buying or selling ABCL?

Accepted Answer

In Q3 2026, Walleye Capital increased its ABCL position from 9 to 139,672 shares.

Question 5

When did Walleye Capital first buy ABCL?

Accepted Answer

Walleye Capital first reported ABCL in its Q1 2021 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	139,672	+15.5Kx	$2M	0.0%	$14.59	42
2026-Q2	Decreased	9	-99.9%	$71	0.0%	$7.85	0
2026-Q1	Decreased	9,780	-96.1%	$34,132	0.0%	$3.49	0
2025-Q4	New	249,050	—	$851,751	0.0%	$3.42	34
2025-Q1	Exited	0	-100.0%	$0	0.0%	$2.23	0
2024-Q4	Decreased	15,000	-94.2%	$43,950	0.0%	$2.93	0
2024-Q3	New	256,881	—	$667,891	0.0%	$2.61	34